Marico's Big Move: Acquisition Talks for Protein Startup Cosmix to Skyrocket Health Business!

CONSUMER-PRODUCTS
Whalesbook Logo
AuthorRiya Kapoor|Published at:
Marico's Big Move: Acquisition Talks for Protein Startup Cosmix to Skyrocket Health Business!
Overview

FMCG giant Marico is in advanced talks to acquire Cosmix, a profitable plant-based protein supplement startup, for approximately ₹300 crore. This strategic move aims to capture the surging demand for protein-rich nutrition in India and bolster Marico's presence in the rapidly growing health and wellness sector. Cosmix, founded in 2019, reported revenues of ₹24.4 crore in FY24 and has shown consistent growth.

Marico Eyes Cosmix Acquisition to Boost Health and Wellness Portfolio

Fast-moving consumer goods (FMCG) major Marico Limited is reportedly in discussions to acquire Cosmix, a startup specializing in plant-based protein supplements. The potential deal, valued at around ₹300 crore, signifies Marico's aggressive strategy to tap into India's booming demand for health and wellness products, particularly protein-rich nutrition.

The Core Issue

India is witnessing a significant shift in consumer preferences, with a growing emphasis on health and fitness. Protein consumption is increasingly seen as crucial for strength building and muscle development, driving demand for supplements and protein-fortified foods. Marico, a well-established player in the consumer goods market, aims to capitalize on this trend by expanding its offerings in the high-growth protein segment.

Financial Implications

The proposed acquisition of Cosmix for approximately ₹300 crore highlights the increasing valuations in the direct-to-consumer (D2C) health space. Cosmix, which has been profitable since its inception in 2019, recorded revenues of ₹24.4 crore and profits of ₹2.8 crore in the fiscal year 2024. Regulatory filings indicate that the company has demonstrated strong growth, expanding over 2.5 times in the past three years, a pace likely maintained in the last fiscal year.

This potential acquisition aligns with Marico's broader strategy of acquiring and scaling D2C brands. The company has a proven track record with previous acquisitions like Plix, True Elements, Beardo, and Just Herbs, which have collectively contributed significantly to its digital business revenues, reaching ₹900 crore as of Q1 FY26. Marico aims to grow its digital business to ₹2,000-2,500 crore within the next three years, employing both organic growth and strategic acquisitions.

Official Statements and Responses

Marico Limited and Cosmix have yet to officially comment on the ongoing acquisition talks, with both entities not responding to queries from Moneycontrol. However, Marico's CEO and Managing Director, Saugata Gupta, had previously acknowledged the importance of the protein category during an analyst call in August, stating, "you have to participate in the category."

Historical Context

Cosmix gained significant visibility after appearing on the popular reality show Shark Tank in 2024. The startup successfully raised ₹1 crore from Emcure Pharmaceuticals' Executive Director Namita Thapar in exchange for 1 percent equity, valuing the company at ₹100 crore at that time. This valuation jump to an estimated ₹300 crore within a year underscores the rapid appreciation of promising D2C brands.

Future Outlook

If the deal materializes, Cosmix will become the latest addition to Marico's growing portfolio of digital-first brands. The consolidation of such brands is expected to create significant value for Marico through cross-selling opportunities and enhanced market penetration in the health and wellness segment. The acquisition would further solidify Marico's position as a key player in India's rapidly evolving consumer landscape.

Impact

This acquisition could significantly boost Marico's revenue streams and market share in the high-growth health and nutrition sector. It reflects a strategic consolidation trend where established FMCG companies acquire innovative D2C brands to stay competitive and cater to changing consumer demands. The deal also represents a substantial wealth creation event for Cosmix's founders and investors, including Namita Thapar.

Impact Rating: 8/10

Difficult Terms Explained

  • FMCG: Fast-Moving Consumer Goods. These are everyday items sold quickly and at a relatively low cost, such as packaged foods, toiletries, and beverages.
  • D2C: Direct-to-Consumer. A business model where companies sell their products directly to customers, bypassing traditional retail intermediaries.
  • FY24: Fiscal Year 2024. Refers to the financial year ending March 31, 2024.
  • Equity: Ownership in a company, often represented by shares.
  • Valuation: The estimated worth of a company, often used in acquisitions and investments.
  • Regulatory filings: Official documents submitted by companies to government bodies, containing financial and operational information.
  • Portfolio: The collection of products or brands owned by a company.
Disclaimer:This content is for educational and informational purposes only and does not constitute investment, financial, or trading advice, nor a recommendation to buy or sell any securities. Readers should consult a SEBI-registered advisor before making investment decisions, as markets involve risk and past performance does not guarantee future results. The publisher and authors accept no liability for any losses. Some content may be AI-generated and may contain errors; accuracy and completeness are not guaranteed. Views expressed do not reflect the publication’s editorial stance.